Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 6/20 | 0.67 |
| ▸ | CA12 | O43570 | 5/20 | 0.66 |
| ▸ | CA7 | P43166 | 5/20 | 0.66 |
| ▸ | CA9 | Q16790 | 5/20 | 0.66 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.66 |
| ▸ | CA1 | P00915 | 4/20 | 0.66 |
| ▸ | CA2 | P00918 | 2/20 | 0.66 |
| ▸ | ESR1 | P03372 | 1/20 | 0.64 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.61 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.61 |
| ▸ | CA4 | P22748 | 3/20 | 0.61 |
| ▸ | CA6 | P23280 | 3/20 | 0.61 |
| ▸ | CA5A | P35218 | 3/20 | 0.61 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.61 |
| ▸ | MET | P08581 | 1/20 | 0.61 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 1/20 | 0.57 |
| ▸ | TYR | P14679 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6151754 | 0.96 | APP (0.72) | APPCA12CA7CA9CA14 | |
| SCHEMBL10007931 | 0.96 | APP (0.72) | APPCA12CA7CA9CA14 | |
| Methane SCHEMBL27971068 | 0.94 | APP (0.70) | APPCA12CA7CA9CA14 | |
| SCHEMBL5548013 | 0.91 | APP (0.72) | APPCA12CA7CA9CA14 | |
| SCHEMBL5548014 | 0.91 | APP (0.72) | APPCA12CA7CA9CA14 | |
| SCHEMBL6397881 | 0.90 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL30946730 | 0.90 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL21001200 | 0.90 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL30516556 | 0.90 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL19359004 | 0.90 | APP (0.73) | APPCA12CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090087590-A1 | OPTICALLY ANISOTROPIC FILM, METHOD OF PRODUCING THE SAME, AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090087590-A1 | OPTICALLY ANISOTROPIC FILM, METHOD OF PRODUCING THE SAME, AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090087590-A1 | OPTICALLY ANISOTROPIC FILM, METHOD OF PRODUCING THE SAME, AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | PYM1, OCIAD1, OCIAD2 | APP 989/4885CA12 2474/4885CA7 2135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.